Public Sector Pension Investment Board (PSP Investments)
CORT icon

Public Sector Pension Investment Board (PSP Investments)’s Corcept Therapeutics CORT Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
334,875
+10,848
+3% +$406K 0.04% 405
2025
Q4 		$11.3M Sell
324,027
-41,811
-11% -$3.28M 0.04% 415
2025
Q3 		$30.4M Buy
365,838
+44,070
+14% +$3.19M 0.11% 123
2025
Q2 		$23.6M Buy
321,768
+26,027
+9% +$1.89M 0.1% 136
2025
Q1 		$33.8M Buy
295,741
+63,407
+27% +$3.86M 0.15% 102
2024
Q4 		$11.7M Buy
232,334
+35,039
+18% +$1.84M 0.05% 279
2024
Q3 		$9.13M Sell
197,295
-4,300
-2% -$153K 0.05% 246
2024
Q2 		$6.55M Buy
201,595
+15,661
+8% +$429K 0.04% 311
2024
Q1 		$4.68M Sell
185,934
-1,330
-0.7% -$31.4K 0.03% 405
2023
Q4 		$6.08M Buy
187,264
+75,727
+68% +$2.08M 0.05% 287
2023
Q3 		$3.04M Sell
111,537
-48,932
-30% -$1.42M 0.02% 546
2023
Q2 		$3.57M Sell
160,469
-8,036
-5% -$185K 0.02% 579
2023
Q1 		$3.65M Sell
168,505
-6,225
-4% -$136K 0.03% 575
2022
Q4 		$3.55M Hold
174,730
– – 0.03% 593
2022
Q3 		$4.48M Sell
174,730
-2,288
-1% -$61.2K 0.04% 400
2022
Q2 		$4.21M Sell
177,018
-921
-0.5% -$20.1K 0.04% 412
2022
Q1 		$4.01M Sell
177,939
-15,500
-8% -$330K 0.02% 590
2021
Q4 		$3.83M Sell
193,439
-17,380
-8% -$353K 0.02% 720
2021
Q3 		$4.15M Sell
210,819
-3,680
-2% -$77K 0.02% 663
2021
Q2 		$4.72M Sell
214,499
-1,080
-0.5% -$24K 0.03% 594
2021
Q1 		$5.13M Sell
215,579
-15,700
-7% -$419K 0.03% 482
2020
Q4 		$6.05M Buy
231,279
+870
+0.4% +$18.3K 0.05% 373
2020
Q3 		$4.01M Hold
230,409
– – 0.03% 498
2020
Q2 		$3.88M Hold
230,409
– – 0.04% 472
2020
Q1 		$2.74M Hold
230,409
– – 0.03% 499
2019
Q4 		$2.79M Sell
230,409
-29,300
-11% -$408K 0.02% 951
2019
Q3 		$3.67M Buy
259,709
+29,164
+13% +$358K 0.02% 717
2019
Q2 		$2.57M Buy
230,545
+134,000
+139% +$1.49M 0.02% 786
2019
Q1 		$1.13M Buy
96,545
+4,000
+4% +$49.7K 0.01% 1010
2018
Q4 		$1.24M Buy
92,545
+19,300
+26% +$255K 0.01% 840
2018
Q3 		$1.03M Buy
73,245
+11,645
+19% +$163K 0.01% 970
2018
Q2 		$968K Hold
61,600
– – 0.01% 838
2018
Q1 		$1.01M Buy
61,600
+1,600
+3% +$29.6K 0.01% 766
2017
Q4 		$1.08M Buy
+60,000
New +$1.09M 0.01% 831

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s CORT Position: Q1 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Corcept Therapeutics (CORT) stake by 3.3% in Q1 2026, buying an estimated $406K and bringing the position to 334,875 shares worth $13.5M. The position accounts for 0.04% of the portfolio, ranked #405.

Public Sector Pension Investment Board (PSP Investments) first reported a position in CORT in Q4 2017 and has held it in 34 quarters since. The position peaked at $33.8M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 334,875 shares of Corcept Therapeutics worth $13.5M as of Q1 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 10,848 Corcept Therapeutics shares in Q1 2026, an estimated $406K.
  • Corcept Therapeutics made up 0.04% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q1 2026, its #405 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Corcept Therapeutics in Q4 2017 and has held it in 34 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Corcept Therapeutics position peaked at $33.8M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q1 2026, filed 13 May 2026.